(VIDEO) In tests so far, the infliximab biosimilar BOW015, just approved in India, seems to look about the same to the human immune system as the original. Here, a VP of the company behind BOW015 talks about the realities of seeking approval in the US.
(ACR2014) (VIDEO) The National Institutes of Health's PROMIS measures, created to study health status in the general population, look good for meaningful outcomes assessment in diseases such as rheumatoid arthritis, says an expert who studies measurement of disability in rheumatic disorders..
The Nod-like receptor (NLR) family of proteins recognizes danger signals within cells, and clearly plays a role in hereditary fever syndromes. Is it also implicated in more prevalent autoinflammatory rheumatic disorders?